南京市2008-2010年不同感染途径和不同报告来源的HIV/AIDS病例的随访率分析

目的分析南京市新发现的艾滋病病毒(HIV)感染者和艾滋病(AIDS)病人(简称HIV/AIDS病人)的不同感染途径和报告来源,对随访管理以及CD4检测的影响。方法收集2008-2010南京市所有报告单位上报的病例及随访资料,对不同感染途径和报告来源的HIV/AIDS病人的随访管理率及CD4检测率进行分析。结果 2008-2010年南京市共报告HIV/AIDS病人955例,随访率呈现上升趋势,CD4检测率总体下降。母婴途径感染者随访率最高(100%),注射吸毒途径感染者随访率最低(71.4%);男男性途径感染者CD4检测率最高(71.3%),注射吸毒途径感染者最低(37.3%)。不同报告来源病例的随访率总体上升,专题调查发现的病例随访率降低;不同报告来源病例的CD4检测率总体下降,但是医院报告病例的CD4检测率上升。结论不同感染途径和病例报告来源对南京市HIV/AIDS病例的随访和CD4检测有不同程度的影响,注射吸毒感染和专题调查发现的病例应成为随访工作的重点,从强化初筛阳性者信息资料的收集入手,提高随访率。

2008-2010 HIV/AIDS case reports and an analysis of follow-up information in Nanjing

Objective To analyze the effects of different routes of transmission and sources of case reporting of newly detected HIV/AIDS cases on the follow-up management and CD4 testing.Methods All the HIV/AIDS cases and their followed up information reported in Nanjing from 2008 to 2010 were collected and were cross-analyzed in the light of follow-up management and CD4 testing of cases infected by different routes of transmissions and reported from different sources.Results From 2008 to 2010,926 HIV/AIDS cases were reported.Follow up rate showed a rising trend while the total CD4 testing rate showed a declining trend.The follow up rate for mother-to-child transmission was the highest(100%) while that for injecting drug users(IDUs) was the lowest(71.4%).The CD4 testing rate was the highest among MSM with homosexual behavior(71.3%) while that among IDUs was the lowest(37.3%);the total follow-up rate among cases reported from different sources was rising while the rate of cases detected by special survey was declining;the total CD4 testing rate of cases reported from different sources was declining while that of cases reported from hospitals was rising.Conclusion Different routes of transmissions and cases reported from different sources exert different effects on the follow up and CD4 testing in Nanjing,and.IDUs and the cases detected by special survey should be placed as focus of follow up and follow up rate could be raised by collecting data of HIV/AIDS cases who are detected HIV positive at screening.